BMC gastroenterology · 2012
Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tack Greetje J, van Wanrooij Roy L J, Von Blomberg B Mary E, Amini Hedayat, Coupe Veerle M H, Bonnet Petra, Mulder Chris J J, Schreurs Marco W J
Аннотация
BACKGROUND: Invasive techniques are still required to distinguish between uncomplicated and complicated forms of CD.
METHODS: We set out to investigate the potential use of novel serum parameters, including IL-6, IL-8, IL-17, IL-22, sCD25, sCD27, granzyme-B, sMICA and sCTLA-4 in patients diagnosed with active CD, CD on a GFD, Refractory coeliac disease (RCD) type I and II, and enteropathy associated T-cell lymphoma (EATL).
RESULTS: In both active CD and RCDI-II elevated levels of the proinflammatory IL-8, IL-17 and sCD25 were observed. In addition, RCDII patients displayed higher serum levels of soluble granzyme-B and IL-6 in comparison to active CD patients. In contrast, no differences between RCDI and active CD or RCDII were observed. Furthermore, EATL patients displayed higher levels of IL-6 as compared to all other groups.
CONCLUSIONS: A series of novel serum parameters reveal distinctive immunological characteristics of RCDII and EATL in comparison to uncomplicated CD and RCDI.
METHODS: We set out to investigate the potential use of novel serum parameters, including IL-6, IL-8, IL-17, IL-22, sCD25, sCD27, granzyme-B, sMICA and sCTLA-4 in patients diagnosed with active CD, CD on a GFD, Refractory coeliac disease (RCD) type I and II, and enteropathy associated T-cell lymphoma (EATL).
RESULTS: In both active CD and RCDI-II elevated levels of the proinflammatory IL-8, IL-17 and sCD25 were observed. In addition, RCDII patients displayed higher serum levels of soluble granzyme-B and IL-6 in comparison to active CD patients. In contrast, no differences between RCDI and active CD or RCDII were observed. Furthermore, EATL patients displayed higher levels of IL-6 as compared to all other groups.
CONCLUSIONS: A series of novel serum parameters reveal distinctive immunological characteristics of RCDII and EATL in comparison to uncomplicated CD and RCDI.
Предметные рубрики MeSH
AdultAgedBiomarkersCTLA-4 AntigenCeliac DiseaseCytokinesDiet, Gluten-FreeEnteropathy-Associated T-Cell LymphomaGranzymesHistocompatibility Antigens Class IHumansInterleukin-17Interleukin-2 Receptor alpha SubunitInterleukin-6Interleukin-8InterleukinsMiddle AgedROC CurveRetrospective StudiesSeverity of Illness IndexStatistics, NonparametricTumor Necrosis Factor Receptor Superfamily, Member 7Young AdultInterleukin-22